.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Novartis
Cipla
US Army
Covington
Johnson and Johnson
Argus Health
Teva
US Department of Justice
Baxter

Generated: December 13, 2017

DrugPatentWatch Database Preview

ADVIL ALLERGY SINUS Drug Profile

« Back to Dashboard

Which patents cover Advil Allergy Sinus, and when can generic versions of Advil Allergy Sinus launch?

Advil Allergy Sinus is a drug marketed by Pfizer and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in eighteen countries.

The generic ingredient in ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
PfizerADVIL ALLERGY SINUSchlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochlorideTABLET;ORAL021441-001Dec 19, 2002OTCYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ADVIL ALLERGY SINUS

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2005120465► Subscribe
China1726035► Subscribe
Peru09732004► Subscribe
Chile2003002653► Subscribe
Australia2011200912► Subscribe
Portugal1572206► Subscribe
Argentina042543► Subscribe
Japan2006515299► Subscribe
World Intellectual Property Organization (WIPO)2004056320► Subscribe
Japan5241228► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fuji
McKesson
QuintilesIMS
Baxter
Julphar
Dow
Citi
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot